Microcannular Tumescent Liposuction in Advanced Lipedema and Dercum’s Disease
Wollina U, Goldman A, Heinig B; 2010
Synopsis: This study evaluated the outcome and risks of tumescence liposuction in patients with advanced lipedema or Dercum’s disease.
Abstract: AIM: We evaluated the outcome and risks of tumescence liposuction in patients with advanced lipedema or Dercum’s disease.
METHODS: Six patients treated at a single center during the years 2004 to 2008 have been included. All patients were female and obese (body mass index 34 to 41.9; mean 38.2+/-3.8) with an age range from 29 to 78 years (mean 55.7+/-20.5 years), five of them had co-morbidities.
RESULTS: The total amount of lipoaspirates varied between 1500 mL and 4800 mL. Pain could be reduced in all four patients with Dercum’s disease. Large adipose tissue removing implies a better the outcome for pain. Patient’s satisfaction was “high” or “very high” in 5 and “medium” in one. The most common adverse effect was met-hemoglobulinemia (N.=4).
CONCLUSION: Tumescence liposuction is a treatment option for lipedema and Dercum’s disease. With careful monitoring the procedure is safe even for patients in advanced stages, higher age and with co-morbidities.
PubMed Link: http://www.ncbi.nlm.nih.gov/pubmed/20467389
Other Link: http://www.researchgate.net/profile/Uwe_Wollina/publication/260063101_Treatment_of_elderly_patients_with_advanced_lipedema_a_combination_of_laser-assisted_liposuction_medial_thigh_lift_and_lower_partial_abdominoplasty/links/00b7d53a562cacc866000000.pdf
APA Citation: Wollina, U., Goldman, A., & Heinig, B. (2010). Microcannular tumescent liposuction in advanced lipedema and Dercums disease. G Ital Dermatol Venereol, 145(2), 151-9.
AMA Citation: Wollina U, Goldman A, Heinig B. Microcannular tumescent liposuction in advanced lipedema and Dercums disease. G Ital Dermatol Venereol. 2010;145(2):151-9.